Skip to main content
. Author manuscript; available in PMC: 2006 Jan 25.
Published in final edited form as: J Bone Joint Surg Am. 2003;85-A Suppl 3:19–28. doi: 10.2106/00004623-200300003-00005

TABLE I.

Alkaline Phosphatase Activity in Human Bone Marrow Cells with and without Dexamethasone Pretreatment*

Primary Culture
First-Passage Culture (nmol product/min/well)
With Dexa methasone? With Dexa methasone? No BMP With BMP-2 P Value for BMP vs. no BMP
Males No No 24.1 ± 11.9 24.2 ± 19.6 >0.3
Yes 78.7 ± 54.7 94.0 ± 57.5 >0.3
Yes No 65.4 ± 17.2 142.0 ± 66.2 0.01
Yes 203.3 ± 64.0 323.6 ± 123.5 0.01
Females No No 24.4 ± 14.9 18.6 ± 11.9 >0.3
Yes 69.2 ± 40.0 78.3 ± 44.3 >0.3
Yes No 41.0 ± 15.8 67.7 ± 24.3 0.02
Yes 137.9 ± 39.6 192.1 ± 60.4 0.03
*

Alkaline phosphatase activity was measured after individually culturing bone marrow cells from twelve men (average age, 45 ± 16 years) and twelve women (average age, 54 ± 11 years). Mononuclear cell samples from each patient were divided into two culture dishes for primary culture, with one of the dishes receiving 10−7M dexamethasone and the other not receiving dexamethasone. At confluence, the dexamethasone-treated cells and untreated cells were each replated (first passage), both with and without dexamethasone, and BMP was added as indicated. All results are the average of samples, assayed in triplicate, from all twelve men or all twelve women.

The values for male cells pretreated with dexamethasone were significantly higher than the values for female cells pretreated with dexamethasone; p < 0.01.

All values with dexamethasone in first passage were significantly higher than those without dexamethasone in first passage; p < 0.01.